Literature DB >> 22257452

[Mucormycosis. An emergent mycosis].

Iris Tiraboschi1, Martín Bravo, Norma Fernández, Daniel Stecher, Marcelo Melero, María Lasala.   

Abstract

Mucormycosis is an opportunistic infection caused by fungi of the order Mucorales. It is characterized by rapid progression and high morbidity and mortality in the absence of early diagnosis and prompt treatment. It was an infrequent disease, but in recent years, its incidence appears to have increased. The aim of this paper is to report the cases of mucormycosis diagnosed from 1982 to 2010 at the Hospital de Clinicas José de San Martín, University of Buenos Aires. We diagnosed 10 cases of mucormycosis; the first three between 1982 and 2004 and the last 7 between 2005 and 2010. The incidence from 1980 to 2004 was 0.13 patient-years and the frequency 0.1/10 000 discharges (95% CI 0.00- 0.3). In the period 2005 to 2010, the incidence was 0.86 patients per year with 1.1/10 000 discharges (95% CI 0.5-2.4). There was a pulmonary mucormycosis case (in a patient treated with corticosteroids) and nine rhinocerebral cases, two in neutropenic and seven in diabetic patients. The diagnosis was made by observation of cenocytic hyphae in 10/10 patients. Mucorales were recovered in 8/9 cultures (5 Rhizopus spp and 3 Mucor spp.). In one case diagnosis of pulmonary mucormycosis was made post-mortem. Nine patients were treated with amphotericin B deoxycholate (in 3 patients supplemented with liposomal amphotericin B) and surgery. Three patients underwent hyperbaric chamber. Seven patients had favorable outcome. In conclusion, mucormycosis is a rare disease, but its incidence has increased over the past five years. A good evolution of the patients is linked to early diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257452

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  3 in total

1.  Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens.

Authors:  Parisa Badiee; Amir Arastefar; Hadis Jafarian
Journal:  Iran J Microbiol       Date:  2013-12

2.  Hepatic failure and malnutrition as predisposing factors of cutaneous mucormycosis in a pediatric patient.

Authors:  Silvia Colman; Gustavo Giusiano; Carmen Colman; María de Los Ángeles Sosa; Florencia Rojas
Journal:  Med Mycol Case Rep       Date:  2021-12-31

Review 3.  Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience.

Authors:  Fiorella Sarubbo; Khaoulah El Haji; Aina Vidal-Balle; Joan Bargay Lleonart
Journal:  Brain Behav Immun Health       Date:  2021-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.